Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,549 INR | -1.42% | -2.23% | +22.99% |
07:46am | Cosmo Pharmaceuticals Partner Gets Regulatory Approval for Acne Treatment in Australia | MT |
06:18am | Sun Pharmaceutical's Acne Drug Gets Approval in Australia | MT |
Sales 2024 * | 485B 5.86B | Sales 2025 * | 538B 6.49B | Capitalization | 3,770B 45.47B |
---|---|---|---|---|---|
Net income 2024 * | 93.12B 1.12B | Net income 2025 * | 113B 1.36B | EV / Sales 2024 * | 7.54 x |
Net cash position 2024 * | 108B 1.31B | Net cash position 2025 * | 166B 2B | EV / Sales 2025 * | 6.69 x |
P/E ratio 2024 * |
40.6
x | P/E ratio 2025 * |
33.5
x | Employees | 41,000 |
Yield 2024 * |
0.77% | Yield 2025 * |
0.89% | Free-Float | 45.32% |
Latest transcript on Sun Pharmaceutical Industries Ltd.
1 day | -0.07% | ||
1 week | -0.89% | ||
Current month | -0.49% | ||
1 month | +2.62% | ||
3 months | +26.12% | ||
6 months | +36.16% | ||
Current year | +24.67% |
Managers | Title | Age | Since |
---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
Founder | 68 | 81-12-31 | |
Director of Finance/CFO | - | 17-06-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 68 | 81-12-31 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21-05-20 |
Rolf K. Hoffmann
BRD | Director/Board Member | 63 | 23-06-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.72% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-19 | 1,549 | -1.42% | 3 293 881 |
24-03-18 | 1,571 | +1.49% | 2,281,873 |
24-03-15 | 1,548 | -1.40% | 3,421,374 |
24-03-14 | 1,570 | +0.74% | 3,062,556 |
24-03-13 | 1,559 | -1.62% | 2,881,503 |
Delayed Quote NSE India S.E., March 19, 2024 at 03:39 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.67% | 45.46B | |
+19.61% | 23.01B | |
+16.54% | 14.49B | |
+4.07% | 13.65B | |
+42.20% | 12.03B | |
-0.24% | 7.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+3.56% | 4.94B | |
+6.46% | 4.67B |